Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO ‑1 pathway activity: Integrating animal experiments and network pharmacology
In conclusion, Res treatment activated the Nrf2/HO‑1 pathway to decrease clinical symptoms, inflammatory responses, and intestinal mucosal barrier damage in experimental UC mice.PMID:38488031 | DOI:10.3892/mmr.2024.13201
Source: Molecular Medicine Reports - Category: Molecular Biology Authors: Xinya Yu Xiaoxi Li Yunchun Xu Yuwei Li Ye Zhou Junhua Zhang Le Guo Source Type: research
More News: Antidoxidants | Databases & Libraries | Drugs & Pharmacology | Inflammatory Bowel Disease | Molecular Biology | Sodium | Study | Ulcerative Colitis